Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Unicycive Therapeutics, Inc.UNCY · Entity 6568 | Director | July 15, 2022 | April 18, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Unicycive Therapeutics, Inc.
Report date July 15, 2022 · Filed April 18, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,738 |
Reported balance
Holding disclosure · report date 2022-07-15 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 41,738 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2022 Filed Aug 30, 2022 21:01 UTC | Unicycive Therapeutics, Inc. UNCY · Entity 6568 | Exercise / conversionRestricted Stock Units · Derivative | 26,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-052329 · ownership.xml · derivative · entry 2 Schiller Brigitte · CIK 0001858938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Unicycive Therapeutics common stock. F3 · derivative.exercise_date: On July 15, 2021, the reporting person was granted 26,738 restricted stock units, all of which vested on July 15, 2022. The common stock into which such vested restricted stock units converted on July 15, 2022 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On July 15, 2021, the reporting person was granted 26,738 restricted stock units, all of which vested on July 15, 2022. The common stock into which such vested restricted stock units converted on July 15, 2022 is reported in Table I on this Form 4. Read SEC document |
| July 15, 2022 Filed Aug 30, 2022 21:01 UTC | Unicycive Therapeutics, Inc. UNCY · Entity 6568 | Exercise / conversionCommon Stock | 26,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-052329 · ownership.xml · nonDerivative · entry 1 Schiller Brigitte · CIK 0001858938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On July 15, 2021, the reporting person was granted 26,738 restricted stock units, all of which vested on July 15, 2022. Read SEC document |
| May 16, 2022 Filed May 17, 2022 15:04 UTC | Unicycive Therapeutics, Inc. UNCY · Entity 6568 | PurchaseCommon Stock | 15,000 | $0.83 | $12,375.00 |
DisclosureSEC source: 0001213900-22-027501 · ownership.xml · nonDerivative · entry 1 Schiller Brigitte · CIK 0001858938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.